Covaxin Gets Emergency Use Approval for Kids Aged 2-18 Years
New Delhi: The Hyderabad-based pharma major Bharat Biotech's Covaxin has got the emergency use approval for children in the age group of 2 to 18 years from the Drugs Controller General of India (DCGA).
The Subject Expert Committee on…